Selank is the calm half of the famous Russian nootropic pair. Semax gets pitched for drive and focus. Selank gets pitched for anxiety without the sleepiness of a sedative. It is a registered medicine in Russia. In the US it is an unapproved research chemical, and unlike Semax, it was not part of the July 2026 FDA peptide review. Here is what the evidence actually supports.
Weak and from one source. The main human study is a small Russian trial from 2008 that compared Selank to an older anti-anxiety drug. It was not blinded and had no placebo. Almost all the mechanism work is in rats and comes from the same Russian research network. We could not find a single Western, independent, placebo-controlled trial.
Selank is a synthetic peptide of seven amino acids. It starts with tuftsin, a small four-amino-acid fragment of an immune protein, and adds the same stabilizing tail used in Semax (Pro-Gly-Pro). That tail helps it last longer in the body.
It is used as nasal drops in Russia. You will also see “N-Acetyl Selank” and “N-Acetyl Selank Amidate” sold online. Those are gray-market variants with no published human data and no regulatory standing anywhere.
Selank was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in Moscow, the same institute behind Semax, working with the Zakusov Institute of Pharmacology. It is registered in Russia as an anti-anxiety medicine in nasal drop form.
The proposed mechanisms are plausible but mostly unproven in people.
GABA. GABA is the brain’s main calming chemical, and it is the system benzodiazepines like Valium work on. A 2016 rat study found Selank changed the activity of dozens of GABA-related genes. The authors suggested it might fine-tune GABA signaling. That is a guess based on gene activity, not proof that Selank binds GABA receptors.
Enkephalins. These are your body’s natural calming and pain-relieving molecules. Selank appears to slow the enzymes that break them down. In the 2008 human trial, a blood marker of enkephalin rose.
BDNF. In rats, Selank raised BDNF, a brain growth factor, in the hippocampus.
Immune effects. Because it comes from tuftsin, Selank also shifts immune signaling. The data here points in different directions, so “immune-modulating” is fair. “Lowers inflammation” is not proven.
The main human study, published in 2008, followed 62 people with generalized anxiety disorder or neurasthenia, a chronic fatigue and nerves diagnosis common in Russian medicine. Thirty got nasal Selank. Thirty-two got medazepam, an older benzodiazepine. The two worked about the same on anxiety scales, and Selank also seemed to lift energy.
The limits are big. There was no placebo. One drug was a nasal spray and the other a pill, so nobody was blinded. It was small, short, and run by the developer’s network. So “as effective as benzodiazepines” stretches one unblinded study a long way.
There are many rodent studies on anxiety and memory, mostly from the same groups. You may also see a “double-blind placebo-controlled trial of 60 patients at 750 mcg a day” cited on vendor sites. We could not find any primary source for it.
Everyday anxiety without sedation, calm focus, and stress resilience. It is very often stacked with Semax. None of these uses is proven by Western standards.
Russian sources report mild effects like nasal irritation and tiredness. Long-term safety, use in pregnancy, interactions with anti-anxiety medications and antidepressants, and dependence have not been properly studied. The FDA flagged a possible risk of immune reactions from clumping and impurities, and noted it lacks important safety information in humans.
If you are already on an anti-anxiety medication or antidepressant, that interaction question is worth taking seriously with a doctor.
Gray-market vials carry the usual risks: wrong dose, wrong substance, contamination, and no sterility guarantee.
Reporting, not a recommendation. Community sources describe nasal use of roughly 250 to 1,000 micrograms a day, split into doses, in cycles of about 10 to 14 days. Some people inject it, which has no basis in the Russian label. We do not give mixing or injection steps.
Not FDA-approved for any use. The FDA placed Selank in Category 2 in 2023. The nominator later withdrew the nomination, so it now sits on the FDA’s list as “nominated but withdrawn.” That is not a ban, but it also means Selank is not on the approved compounding list and cannot lawfully be compounded from bulk.
Selank was not reviewed at the July 2026 Pharmacy Compounding Advisory Committee meeting. Some sites say it was. That is wrong. The seven reviewed were BPC-157, TB-500, KPV, MOTS-c, Semax, Epitalon and DSIP. We found no FDA advisory meeting that has ever reviewed Selank.
Selank is not named on the WADA list, but it very likely falls under the “non-approved substances” category, which is banned at all times.
Is Selank FDA-approved? No.
Was it part of the 2026 FDA peptide review? No. Semax was. Selank was not.
Does it work for anxiety? Small, unblinded Russian studies suggest an effect similar to an older benzodiazepine. There are no independent placebo-controlled trials.
Selank or Semax? They are related Russian peptides. Selank is aimed at anxiety. Semax is aimed at focus and stroke recovery.
Is it sedating or addictive? Russian studies report little sedation. Dependence has not been properly studied.
What is N-Acetyl Selank? A modified version sold online with no published human data.
Is it banned in sport? Probably, under WADA’s non-approved substances category.
Plain-language updates on new research and the shifting rules. No hype, unsubscribe anytime.